Vesalius Longevity Labs Inc.

Vesalius Longevity Labs is building a global leading peptide and longevity company and the first publicly traded platform dedicated to physician-prescribed peptide therapeutics.

Nouvelles récentes

Vesalius Longevity Labs Commences Trading Today on the Canadian Securities Exchange Under the Symbol "VLAB"

British Columbia and Scottsdale, Arizona--(Newsfile Corp. - November 12, 2026) - Vesalius Longevity Labs Inc. (CSE: VLAB) ("Vesalius" or the "Company") is pleased to announce that it will commence trading on the Canadian Securities Exchange ("CSE") under the symbol "VLAB" today, November 12, 2026. "Today marks an important milestone for Vesalius Labs, and I want to sincerely thank our Board of Directors, our entire team, and our shareholders and stakeholders for their support and guidance...

2026-11-12 7:00 AM EST

Prêt à annoncer en toute confiance?

Envoyez-nous un message, et un membre de notre équipe TMX Newsfile communiquera avec vous pour discuter de vos besoins.

Communiquez avec nous